APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-animal Type Hard Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-animal Type Hard Capsules Market Outlook and Growth Opportunities 2026

Report ID 174017510422 December 2025201 pages

Choose your research edition.

Industry ResearchNon-animal Type Hard Capsules Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-animal Type Hard Capsules Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Non-animal Type Hard Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-animal Type Hard Capsules Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-animal Type Hard Capsules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Non-animal Type Hard Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-animal Type Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-animal Type Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-animal Type Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-animal Type Hard Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-animal Type Hard Capsules market include Lonza, Hunan Er-Kang Pharmaceutical Co., Ltd, Sunil Healthcare, Roxlor, Qualicaps (Mitsubishi Chemical), Procaps S.A, Pharco, Patheon (Banner Pharmacaps) and Medicaps, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-animal Type Hard Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-animal Type Hard Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-animal Type Hard Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-animal Type Hard Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-animal Type Hard Capsules Segment by Company

Lonza

Hunan Er-Kang Pharmaceutical Co., Ltd

Sunil Healthcare

Roxlor

Qualicaps (Mitsubishi Chemical)

Procaps S.A

Pharco

Patheon (Banner Pharmacaps)

Medicaps

Jedco International Pharmaceutical

JC Biological Technology

Catalent

CapsCanada

Bahrain Pharma

Arab-Caps

Aenova

ACPL

ACG Associated Capsules

Non-animal Type Hard Capsules Segment by Type

Type I

00E

0E

Non-animal Type Hard Capsules Segment by Application

Pharmaceutical

Nutraceutical

Cosmetics

Non-animal Type Hard Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-animal Type Hard Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-animal Type Hard Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-animal Type Hard Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Non-animal Type Hard Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-animal Type Hard Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-animal Type Hard Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-animal Type Hard Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-animal Type Hard Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-animal Type Hard Capsules industry.

Chapter 3: Detailed analysis of Non-animal Type Hard Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-animal Type Hard Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-animal Type Hard Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-animal Type Hard Capsules Industry Trends Table 2. Non-animal Type Hard Capsules Industry Drivers Table 3. Non-animal Type Hard Capsules Industry Opportunities and Challenges Table 4. Non-animal Type Hard Capsules Industry Restraints Table 5. Global Non-animal Type Hard Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-animal Type Hard Capsules Revenue Share by Company (2021-2026) Table 7. Global Non-animal Type Hard Capsules Sales Volume by Company (k units) & (2021-2026) Table 8. Global Non-animal Type Hard Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Non-animal Type Hard Capsules Average Price (US$/unit) of Company (2021-2026) Table 10. Global Non-animal Type Hard Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-animal Type Hard Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Non-animal Type Hard Capsules Company, Product Type & Application Table 13. Global Non-animal Type Hard Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-animal Type Hard Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Type I Table 18. Significant Companies of 00E Table 19. Significant Companies of 0E Table 20. Global Non-animal Type Hard Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Non-animal Type Hard Capsules Sales Volume by Type (2021-2026) & (k units) Table 22. Global Non-animal Type Hard Capsules Sales Volume by Type (2027-2032) & (k units) Table 23. Global Non-animal Type Hard Capsules Sales Volume Share by Type (2021-2026) Table 24. Global Non-animal Type Hard Capsules Sales Volume Share by Type (2027-2032) Table 25. Global Non-animal Type Hard Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Non-animal Type Hard Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Non-animal Type Hard Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Non-animal Type Hard Capsules Sales Value Share by Type (2021-2026) Table 29. Global Non-animal Type Hard Capsules Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharmaceutical Table 31. Significant Companies of Nutraceutical Table 32. Significant Companies of Cosmetics Table 33. Global Non-animal Type Hard Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Non-animal Type Hard Capsules Sales Volume by Application (2021-2026) & (k units) Table 35. Global Non-animal Type Hard Capsules Sales Volume by Application (2027-2032) & (k units) Table 36. Global Non-animal Type Hard Capsules Sales Volume Share by Application (2021-2026) Table 37. Global Non-animal Type Hard Capsules Sales Volume Share by Application (2027-2032) Table 38. Global Non-animal Type Hard Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Non-animal Type Hard Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Non-animal Type Hard Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Non-animal Type Hard Capsules Sales Value Share by Application (2021-2026) Table 42. Global Non-animal Type Hard Capsules Sales Value Share by Application (2027-2032) Table 43. Global Non-animal Type Hard Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Non-animal Type Hard Capsules Sales by Region (2021-2026) & (k units) Table 45. Global Non-animal Type Hard Capsules Sales Market Share by Region (2021-2026) Table 46. Global Non-animal Type Hard Capsules Sales by Region (2027-2032) & (k units) Table 47. Global Non-animal Type Hard Capsules Sales Market Share by Region (2027-2032) Table 48. Global Non-animal Type Hard Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Non-animal Type Hard Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Non-animal Type Hard Capsules Sales Value Share by Region (2021-2026) Table 51. Global Non-animal Type Hard Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Non-animal Type Hard Capsules Sales Value Share by Region (2027-2032) Table 53. Global Non-animal Type Hard Capsules Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Non-animal Type Hard Capsules Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Non-animal Type Hard Capsules Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Non-animal Type Hard Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 58. Global Non-animal Type Hard Capsules Sales Market Share by Country (2021-2026) Table 59. Global Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 60. Global Non-animal Type Hard Capsules Sales Market Share by Country (2027-2032) Table 61. Global Non-animal Type Hard Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Non-animal Type Hard Capsules Sales Value Market Share by Country (2021-2026) Table 63. Global Non-animal Type Hard Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Non-animal Type Hard Capsules Sales Value Market Share by Country (2027-2032) Table 65. Lonza Company Information Table 66. Lonza Business Overview Table 67. Lonza Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Lonza Non-animal Type Hard Capsules Product Portfolio Table 69. Lonza Recent Development Table 70. Hunan Er-Kang Pharmaceutical Co., Ltd Company Information Table 71. Hunan Er-Kang Pharmaceutical Co., Ltd Business Overview Table 72. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio Table 74. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Development Table 75. Sunil Healthcare Company Information Table 76. Sunil Healthcare Business Overview Table 77. Sunil Healthcare Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio Table 79. Sunil Healthcare Recent Development Table 80. Roxlor Company Information Table 81. Roxlor Business Overview Table 82. Roxlor Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Roxlor Non-animal Type Hard Capsules Product Portfolio Table 84. Roxlor Recent Development Table 85. Qualicaps (Mitsubishi Chemical) Company Information Table 86. Qualicaps (Mitsubishi Chemical) Business Overview Table 87. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio Table 89. Qualicaps (Mitsubishi Chemical) Recent Development Table 90. Procaps S.A Company Information Table 91. Procaps S.A Business Overview Table 92. Procaps S.A Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Procaps S.A Non-animal Type Hard Capsules Product Portfolio Table 94. Procaps S.A Recent Development Table 95. Pharco Company Information Table 96. Pharco Business Overview Table 97. Pharco Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Pharco Non-animal Type Hard Capsules Product Portfolio Table 99. Pharco Recent Development Table 100. Patheon (Banner Pharmacaps) Company Information Table 101. Patheon (Banner Pharmacaps) Business Overview Table 102. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio Table 104. Patheon (Banner Pharmacaps) Recent Development Table 105. Medicaps Company Information Table 106. Medicaps Business Overview Table 107. Medicaps Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Medicaps Non-animal Type Hard Capsules Product Portfolio Table 109. Medicaps Recent Development Table 110. Jedco International Pharmaceutical Company Information Table 111. Jedco International Pharmaceutical Business Overview Table 112. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio Table 114. Jedco International Pharmaceutical Recent Development Table 115. JC Biological Technology Company Information Table 116. JC Biological Technology Business Overview Table 117. JC Biological Technology Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. JC Biological Technology Non-animal Type Hard Capsules Product Portfolio Table 119. JC Biological Technology Recent Development Table 120. Catalent Company Information Table 121. Catalent Business Overview Table 122. Catalent Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Catalent Non-animal Type Hard Capsules Product Portfolio Table 124. Catalent Recent Development Table 125. CapsCanada Company Information Table 126. CapsCanada Business Overview Table 127. CapsCanada Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. CapsCanada Non-animal Type Hard Capsules Product Portfolio Table 129. CapsCanada Recent Development Table 130. Bahrain Pharma Company Information Table 131. Bahrain Pharma Business Overview Table 132. Bahrain Pharma Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio Table 134. Bahrain Pharma Recent Development Table 135. Arab-Caps Company Information Table 136. Arab-Caps Business Overview Table 137. Arab-Caps Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Arab-Caps Non-animal Type Hard Capsules Product Portfolio Table 139. Arab-Caps Recent Development Table 140. Aenova Company Information Table 141. Aenova Business Overview Table 142. Aenova Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. Aenova Non-animal Type Hard Capsules Product Portfolio Table 144. Aenova Recent Development Table 145. ACPL Company Information Table 146. ACPL Business Overview Table 147. ACPL Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. ACPL Non-animal Type Hard Capsules Product Portfolio Table 149. ACPL Recent Development Table 150. ACG Associated Capsules Company Information Table 151. ACG Associated Capsules Business Overview Table 152. ACG Associated Capsules Non-animal Type Hard Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 153. ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio Table 154. ACG Associated Capsules Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Non-animal Type Hard Capsules Distributors List Table 158. Non-animal Type Hard Capsules Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Non-animal Type Hard Capsules Product Image Figure 2. Global Non-animal Type Hard Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-animal Type Hard Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-animal Type Hard Capsules Sales (2021-2032) & (k units) Figure 5. Global Non-animal Type Hard Capsules Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Non-animal Type Hard Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Type I Image Figure 10. 00E Image Figure 11. 0E Image Figure 12. Global Non-animal Type Hard Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Non-animal Type Hard Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Non-animal Type Hard Capsules Sales Volume Share by Type (2021-2032) Figure 15. Global Non-animal Type Hard Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Non-animal Type Hard Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Non-animal Type Hard Capsules Sales Value Share by Type (2021-2032) Figure 18. Pharmaceutical Image Figure 19. Nutraceutical Image Figure 20. Cosmetics Image Figure 21. Global Non-animal Type Hard Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Non-animal Type Hard Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Non-animal Type Hard Capsules Sales Volume Share by Application (2021-2032) Figure 24. Global Non-animal Type Hard Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Non-animal Type Hard Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Non-animal Type Hard Capsules Sales Value Share by Application (2021-2032) Figure 27. Global Non-animal Type Hard Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Non-animal Type Hard Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Non-animal Type Hard Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Non-animal Type Hard Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Non-animal Type Hard Capsules Sales Value (2021-2032) & (US$ Million) Figure 32. North America Non-animal Type Hard Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Non-animal Type Hard Capsules Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Non-animal Type Hard Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Non-animal Type Hard Capsules Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Non-animal Type Hard Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Non-animal Type Hard Capsules Sales Value (2021-2032) & (US$ Million) Figure 38. South America Non-animal Type Hard Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Non-animal Type Hard Capsules Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Non-animal Type Hard Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Non-animal Type Hard Capsules Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Non-animal Type Hard Capsules Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Type I
  • 00E
  • 0E
Applications
  • Pharmaceutical
  • Nutraceutical
  • Cosmetics
Companies covered
  • Lonza
  • Hunan Er-Kang Pharmaceutical Co., Ltd
  • Sunil Healthcare
  • Roxlor
  • Qualicaps (Mitsubishi Chemical)
  • Procaps S.A
  • Pharco
  • Patheon (Banner Pharmacaps)
  • Medicaps
  • Jedco International Pharmaceutical
  • JC Biological Technology
  • Catalent
  • CapsCanada
  • Bahrain Pharma
  • Arab-Caps
  • Aenova
  • ACPL
  • ACG Associated Capsules

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-animal Type Hard Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Non-animal Type Hard Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Non-animal Type Hard Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-animal Type Hard Capsules Market Dynamics
  1. 2.1 Non-animal Type Hard Capsules Industry Trends
  2. 2.2 Non-animal Type Hard Capsules Industry Drivers
  3. 2.3 Non-animal Type Hard Capsules Industry Opportunities and Challenges
  4. 2.4 Non-animal Type Hard Capsules Industry Restraints
3 Non-animal Type Hard Capsules Market by Company
  1. 3.1 Global Non-animal Type Hard Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Non-animal Type Hard Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Non-animal Type Hard Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-animal Type Hard Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Non-animal Type Hard Capsules Company Ranking (2024-2026)
  6. 3.6 Global Non-animal Type Hard Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-animal Type Hard Capsules Company Product Type and Application
  8. 3.8 Global Non-animal Type Hard Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-animal Type Hard Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-animal Type Hard Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-animal Type Hard Capsules Market by Type
  1. 4.1 Non-animal Type Hard Capsules Type Introduction
  2. 4.1.1 Type I
  3. 4.1.2 00E
  4. 4.1.3 0E
  5. 4.2 Global Non-animal Type Hard Capsules Sales Volume by Type
  6. 4.2.1 Global Non-animal Type Hard Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Non-animal Type Hard Capsules Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Non-animal Type Hard Capsules Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Non-animal Type Hard Capsules Sales Value by Type
  10. 4.3.1 Global Non-animal Type Hard Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Non-animal Type Hard Capsules Sales Value by Type (2021-2032)
  12. 4.3.3 Global Non-animal Type Hard Capsules Sales Value Share by Type (2021-2032)
5 Non-animal Type Hard Capsules Market by Application
  1. 5.1 Non-animal Type Hard Capsules Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Nutraceutical
  4. 5.1.3 Cosmetics
  5. 5.2 Global Non-animal Type Hard Capsules Sales Volume by Application
  6. 5.2.1 Global Non-animal Type Hard Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-animal Type Hard Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Non-animal Type Hard Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Non-animal Type Hard Capsules Sales Value by Application
  10. 5.3.1 Global Non-animal Type Hard Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-animal Type Hard Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Non-animal Type Hard Capsules Sales Value Share by Application (2021-2032)
6 Non-animal Type Hard Capsules Regional Sales and Value Analysis
  1. 6.1 Global Non-animal Type Hard Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-animal Type Hard Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Non-animal Type Hard Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Non-animal Type Hard Capsules Sales by Region (2027-2032)
  5. 6.3 Global Non-animal Type Hard Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-animal Type Hard Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-animal Type Hard Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-animal Type Hard Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Non-animal Type Hard Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-animal Type Hard Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Non-animal Type Hard Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-animal Type Hard Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Non-animal Type Hard Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-animal Type Hard Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-animal Type Hard Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-animal Type Hard Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Non-animal Type Hard Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-animal Type Hard Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-animal Type Hard Capsules Sales Value Share by Country, 2025 VS 2032
7 Non-animal Type Hard Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Non-animal Type Hard Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-animal Type Hard Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-animal Type Hard Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Non-animal Type Hard Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Non-animal Type Hard Capsules Sales by Country (2027-2032)
  6. 7.4 Global Non-animal Type Hard Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-animal Type Hard Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-animal Type Hard Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-animal Type Hard Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-animal Type Hard Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-animal Type Hard Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza
  2. 8.1.1 Lonza Company Information
  3. 8.1.2 Lonza Business Overview
  4. 8.1.3 Lonza Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Non-animal Type Hard Capsules Product Portfolio
  6. 8.1.5 Lonza Recent Developments
  7. 8.2 Hunan Er-Kang Pharmaceutical Co., Ltd
  8. 8.2.1 Hunan Er-Kang Pharmaceutical Co., Ltd Company Information
  9. 8.2.2 Hunan Er-Kang Pharmaceutical Co., Ltd Business Overview
  10. 8.2.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio
  12. 8.2.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments
  13. 8.3 Sunil Healthcare
  14. 8.3.1 Sunil Healthcare Company Information
  15. 8.3.2 Sunil Healthcare Business Overview
  16. 8.3.3 Sunil Healthcare Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio
  18. 8.3.5 Sunil Healthcare Recent Developments
  19. 8.4 Roxlor
  20. 8.4.1 Roxlor Company Information
  21. 8.4.2 Roxlor Business Overview
  22. 8.4.3 Roxlor Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roxlor Non-animal Type Hard Capsules Product Portfolio
  24. 8.4.5 Roxlor Recent Developments
  25. 8.5 Qualicaps (Mitsubishi Chemical)
  26. 8.5.1 Qualicaps (Mitsubishi Chemical) Company Information
  27. 8.5.2 Qualicaps (Mitsubishi Chemical) Business Overview
  28. 8.5.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio
  30. 8.5.5 Qualicaps (Mitsubishi Chemical) Recent Developments
  31. 8.6 Procaps S.A
  32. 8.6.1 Procaps S.A Company Information
  33. 8.6.2 Procaps S.A Business Overview
  34. 8.6.3 Procaps S.A Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Procaps S.A Non-animal Type Hard Capsules Product Portfolio
  36. 8.6.5 Procaps S.A Recent Developments
  37. 8.7 Pharco
  38. 8.7.1 Pharco Company Information
  39. 8.7.2 Pharco Business Overview
  40. 8.7.3 Pharco Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pharco Non-animal Type Hard Capsules Product Portfolio
  42. 8.7.5 Pharco Recent Developments
  43. 8.8 Patheon (Banner Pharmacaps)
  44. 8.8.1 Patheon (Banner Pharmacaps) Company Information
  45. 8.8.2 Patheon (Banner Pharmacaps) Business Overview
  46. 8.8.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio
  48. 8.8.5 Patheon (Banner Pharmacaps) Recent Developments
  49. 8.9 Medicaps
  50. 8.9.1 Medicaps Company Information
  51. 8.9.2 Medicaps Business Overview
  52. 8.9.3 Medicaps Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Medicaps Non-animal Type Hard Capsules Product Portfolio
  54. 8.9.5 Medicaps Recent Developments
  55. 8.10 Jedco International Pharmaceutical
  56. 8.10.1 Jedco International Pharmaceutical Company Information
  57. 8.10.2 Jedco International Pharmaceutical Business Overview
  58. 8.10.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio
  60. 8.10.5 Jedco International Pharmaceutical Recent Developments
  61. 8.11 JC Biological Technology
  62. 8.11.1 JC Biological Technology Company Information
  63. 8.11.2 JC Biological Technology Business Overview
  64. 8.11.3 JC Biological Technology Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 JC Biological Technology Non-animal Type Hard Capsules Product Portfolio
  66. 8.11.5 JC Biological Technology Recent Developments
  67. 8.12 Catalent
  68. 8.12.1 Catalent Company Information
  69. 8.12.2 Catalent Business Overview
  70. 8.12.3 Catalent Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Catalent Non-animal Type Hard Capsules Product Portfolio
  72. 8.12.5 Catalent Recent Developments
  73. 8.13 CapsCanada
  74. 8.13.1 CapsCanada Company Information
  75. 8.13.2 CapsCanada Business Overview
  76. 8.13.3 CapsCanada Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CapsCanada Non-animal Type Hard Capsules Product Portfolio
  78. 8.13.5 CapsCanada Recent Developments
  79. 8.14 Bahrain Pharma
  80. 8.14.1 Bahrain Pharma Company Information
  81. 8.14.2 Bahrain Pharma Business Overview
  82. 8.14.3 Bahrain Pharma Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio
  84. 8.14.5 Bahrain Pharma Recent Developments
  85. 8.15 Arab-Caps
  86. 8.15.1 Arab-Caps Company Information
  87. 8.15.2 Arab-Caps Business Overview
  88. 8.15.3 Arab-Caps Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Arab-Caps Non-animal Type Hard Capsules Product Portfolio
  90. 8.15.5 Arab-Caps Recent Developments
  91. 8.16 Aenova
  92. 8.16.1 Aenova Company Information
  93. 8.16.2 Aenova Business Overview
  94. 8.16.3 Aenova Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Aenova Non-animal Type Hard Capsules Product Portfolio
  96. 8.16.5 Aenova Recent Developments
  97. 8.17 ACPL
  98. 8.17.1 ACPL Company Information
  99. 8.17.2 ACPL Business Overview
  100. 8.17.3 ACPL Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 ACPL Non-animal Type Hard Capsules Product Portfolio
  102. 8.17.5 ACPL Recent Developments
  103. 8.18 ACG Associated Capsules
  104. 8.18.1 ACG Associated Capsules Company Information
  105. 8.18.2 ACG Associated Capsules Business Overview
  106. 8.18.3 ACG Associated Capsules Non-animal Type Hard Capsules Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio
  108. 8.18.5 ACG Associated Capsules Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-animal Type Hard Capsules Value Chain Analysis
  2. 9.1.1 Non-animal Type Hard Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-animal Type Hard Capsules Sales Mode & Process
  6. 9.2 Non-animal Type Hard Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-animal Type Hard Capsules Distributors
  9. 9.2.3 Non-animal Type Hard Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst